NCT03937011

Brief Summary

This single-arm, prospective, observational multicenter study will collect clinical data in a post-market setting across two different specialties in Robotic surgical procedures: Bariatric Sleeve gastrectomy (Staple line reinforcement) and Hysterectomy (Vaginal cuff closure). Investigators will perform the procedure using SFX Spiral PDS Plus in compliance with their standard surgical approach and the IFU.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
161

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2019

Longer than P75 for all trials

Geographic Reach
3 countries

8 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 3, 2019

Completed
7 months until next milestone

Study Start

First participant enrolled

December 11, 2019

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 10, 2023

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 13, 2023

Completed
Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

3.4 years

First QC Date

April 26, 2019

Last Update Submit

February 12, 2026

Conditions

Keywords

STRATAFIX SPIRAL PDS PLUS, ROBOTIC SUTURING,

Outcome Measures

Primary Outcomes (1)

  • Percentage of subjects with no bleeding or mild bleeding (defined as success) at the completion of the suturing at the organ layer (vaginal cuff closure or gastric staple line reinforcement using STRATAFIX™ Spiral PDS™ Plus).

    The bleeding grade assessment used for the primary endpoint will be made right after the suturing is completed. Any re-bleeding after the initial assessment (just before the removal of the optics and trocars) from the suture line after this assessment will be considered a failure for the primary performance endpoint.

    Intra-op assessment (During Surgery; after suturing of the target tissue, Day of surgery)

Secondary Outcomes (10)

  • Qualitative Assessment of Suture Handling

    Intra-op (at surgery, after suturing of the target tissue layer, Day of surgery)

  • Time to Closure (in minutes/seconds)

    Intra-op (during suturing of the target tissue, Day of surgery)

  • Overall procedure time (first incision to skin closure)

    Intra-op (during the surgery, Day of surgery)

  • Length of stay in hours

    Post-Operative up to 48 hrs

  • Estimated intra-operative blood loss per institutional standard of care and incidence of subjects requiring blood transfusion

    Intra-Op (during the surgery, Day of surgery)

  • +5 more secondary outcomes

Study Arms (1)

Stratafix Arm

The single study arm would comprise of two different specialties in Robotic surgical procedures: Bariatric Sleeve gastrectomy (Staple line reinforcement) and Hysterectomy (Vaginal cuff closure).

Device: Robotic Suturing of gastric sleeve oversew and vaginal cuff closure

Interventions

1. Robotic Bariatric Sleeve gastrectomy 2. Robotic Hysterectomy with or without oophorectomy;

Stratafix Arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Subjects ≥ 18 years who are undergoing elective/non-emergent gastric or gynecological procedures robotically

You may qualify if:

  • Elect to have a Robotic Bariatric Sleeve Gastrectomy or Robotic Total Hysterectomy where STRATAFIX™ Spiral PDS™ Plus device is used for staple line re-enforcement or vaginal cuff closure, respectively
  • Are willing and able to give consent and comply with all study-related evaluations and treatment scheduled
  • Subjects are ≥ 18 years of age

You may not qualify if:

  • Physical or psychological condition which would impair study participation or are unwilling or unable to participate in all required study visits
  • Any pre-operative or intra-operative findings identified by the surgeon that may preclude the use of study product
  • Enrolled in a concurrent clinical study (drug/device) that might affect current study primary or secondary endpoints
  • Allergic to poly (p-dioxanon), IRGACARE®\* MP (triclosan) or D\&C Violet No. 2 colorant
  • Pregnant or lactating female subjects as confirmed prior to the procedure
  • Subjects undergoing radical hysterectomy (Type B, C and D) according to Querleu \& Morrow classification or gastric sleeve revision surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

Baptist Health South Florida

Miami, Florida, 33173, United States

Location

Albany Medical

Albany, New York, 12208, United States

Location

Mt. Sinai

New York, New York, 10029, United States

Location

Lenox Hill hospital

New York, New York, 10075, United States

Location

Universitaetsklinikum Hamburg Eppendorf

Hamburg, Germany

Location

Klinuk fur Allgemelne, Viszeral-ThoraxTransplantations- und Kinderchirurgie

Kiel, Germany

Location

University of Naples

Naples, Italy

Location

University Pisa

Pisa, Italy

Location

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2019

First Posted

May 3, 2019

Study Start

December 11, 2019

Primary Completion

May 10, 2023

Study Completion

November 13, 2023

Last Updated

February 17, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Johnson \& Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu

More information

Locations